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death. Establishing early diagnosis and proper treatment may be
the key for a good outcome and prognosis improvement.
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Ps® 7630 (Umckaloabo®), an extract from Pelargonium
idoides roots, exerts anti-inﬂuenza virus activity in vitro and
n vivo
.L. Theisen, S. Gohrbandt, C.P. Muller, N. Luetteke ∗
Centre de Recherche Public de la Santé / National Public Health Labo-
atory, Luxembourg, Luxembourg
Background: A prodelphinidin-rich extract from Pelargonium
idoides DC, EPs® 7630 (Umckaloabo®), which is licensed to treat
espiratory tract infections such as acute bronchitis, was investi-
ated for its antiviral effects.
Methods: The efﬁcacy of EPs® 7630 on inﬂuenza A virus prop-
gation was investigated in vitro against different strains, after
ifferent infection and treatment timepoints andbyneuraminidase
nd hemagglutination inhibition assays. Isolated monomers,
imers and oligo-/polymeric fractions were compared for antivi-
al activity. In vivo, EPs® 7630 was investigated after inhalative
pplication.
Results: EPs® 7630 showed dose-dependent anti-inﬂuenza
ctivity at non toxic concentrations against pandemic H1N1,
seltamivir sensitive and resistant seasonal H1N1, seasonal H3N2
nd the laboratory H1N1 strain A/Puerto Rico/8/34, while it had
o antiviral activity against adenovirus or measles virus. The
xtract inhibited an early step of inﬂuenza infection and impaired
iral hemagglutination as well as neuraminidase activity. How-
ver, EPs® 7630 did not exhibit a direct virucidal effect, as virus
reincubation (unlike cell preincubation) with the extract did not
nﬂuence infectivity. Analysis of EPs® 7630 constituents revealed
hat prodelphinidins represent the active principle. Chain length
nﬂuenced antiviral activity, as monomers and dimers were less
ffective than oligo- and polymers. Importantly, gallocatechin and
ts stereoisomer epigallocatechin exert antiviral activity also in
heir monomeric form. In addition, EPs® 7630 administered by
nhalation signiﬁcantly improved survival, body weight and body
emperature of inﬂuenza-infected mice, without obvious toxicity,
emonstrating the beneﬁt of EPs® 7630 in treatment of inﬂuenza.
Conclusion: In this study, we investigated the anti-inﬂuenza
echanism of EPs® 7630 and demonstrate its efﬁcacy in vitro and
n vivo. The extract shows a robust effect against multiple different
AV strains in vitro and protection of mice against a lethal virus
hallenge at non-toxic concentrations, underlining the beneﬁt of
Ps® 7630 as a treatment for inﬂuenza virus infection.
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Acute encephalitis in children caused by inﬂuenza virus-AH1N1
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Romania
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Background: Worldwide, seasonal ﬂu epidemics remains a
majorpublic healthproblem.Most recentpandemic inﬂuenza,with
AH1N1 virus, also included Romania. Acute encephalitis is one of
the most severe complications of inﬂuenza in children.
Methods: In this article, we present two clinical cases of acute
encephalitis in children caused by AH1N1 inﬂuenza virus, that
were hospitalized in Pediatric Intensive care unit of the National
Institute of Infectious Diseases “Prof. Dr. Matei Bals” in Bucharest.
Positive diagnosis was established on clinical, epidemiological and
laboratory data. Diagnosis conﬁrmation was made by RT-PCR from
nasal-pharyngeal secretions of patients. MRI examination was per-
formed in both cases and it showed disseminated encephalitis
outbreaks located especially in the brainsteam, in the ﬁrst case and
for the second patient subarachnoid hemorrhage with the absence
of cerebral circulation. The EEG examination conﬁrmed the diag-
nosis for both patients. They both were treated with Oseltamivir
and cortisone in high doses.
Results: The outcome for both patients was grave, the ﬁrst one
presented severe mental and physical retardation and the second
one required oral-tracheal intubation and mechanical ventilation
for 90 days but still had fatal evolution.
Conclusion:TheﬂucausedbyAH1N1virus canhave severe evo-
lution into encephalitis or other neurological complications or even
